Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Valvular Heart Disease

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 215 articles:
HTML format



Single Articles


    June 2021
  1. DEMER LL, Tintut Y
    Hearts of Stone: Calcific Aortic Stenosis and Antiresorptive Agents for Osteoporosis.
    Circulation. 2021;143:2428-2430.
    PubMed    


  2. TAM DY, Wijeysundera HC
    A Real-World Examination of Embolic Protection Devices for Transcatheter Aortic Valve Replacement.
    Circulation. 2021;143:2241-2243.
    PubMed    


    May 2021
  3. KAR S, Mack MJ, Lindenfeld J, Abraham WT, et al
    Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure: The COAPT Trial.
    Circulation. 2021 May 27. doi: 10.1161/CIRCULATIONAHA.120.053061.
    PubMed     Abstract available


  4. SHROFF GR, Bangalore S, Bhave NM, Chang TI, et al
    Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2021 May 13:CIR0000000000000979. doi: 10.1161/CIR.0000000000000979.
    PubMed     Abstract available


    April 2021
  5. PAWADE TA, Doris MK, Bing R, White AC, et al
    Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial.
    Circulation. 2021 Apr 29. doi: 10.1161/CIRCULATIONAHA.121.053708.
    PubMed     Abstract available


  6. LINDMAN BR, Merryman WD
    Unloading the Stenotic Path to Identifying Medical Therapy for Calcific Aortic Valve Disease: Barriers and Opportunities.
    Circulation. 2021;143:1455-1457.
    PubMed    


    March 2021
  7. KIM WK, Walther T, Burgdorf C, Mollmann H, et al
    One-Year Outcomes of a Randomized Trial Comparing a Self-Expanding With a Balloon-Expandable Transcatheter Aortic Valve.
    Circulation. 2021;143:1267-1269.
    PubMed    


  8. CONSTANT DIT BEAUFILS AL, Huttin O, Jobbe-Duval A, Senage T, et al
    Replacement Myocardial Fibrosis in Patients with Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling and Arrhythmia.
    Circulation. 2021 Mar 12. doi: 10.1161/CIRCULATIONAHA.120.050214.
    PubMed     Abstract available



  9. Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2021;143:e784.
    PubMed    


  10. VINCENT F, Ternacle J, Denimal T, Shen M, et al
    Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis.
    Circulation. 2021;143:1043-1061.
    PubMed     Abstract available


    February 2021
  11. BUTALA NM, Makkar R, Secemsky EA, Gallup D, et al
    Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results from the TVT Registry.
    Circulation. 2021 Feb 23. doi: 10.1161/CIRCULATIONAHA.120.052874.
    PubMed     Abstract available


  12. WORKMAN V, Forrest JK, Enriquez A
    A Case of Presyncope After Transcatheter Aortic Valve Replacement.
    Circulation. 2021;143:857-861.
    PubMed    


  13. SHAH SV, Bavry AA, Kumbhani DJ
    Transcatheter Mitral Valve Edge-to-Edge Repair for Secondary Mitral Regurgitation: Why Sex Matters.
    Circulation. 2021;143:621-623.
    PubMed    



  14. Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2021;143:e228.
    PubMed    



  15. Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2021;143:e229.
    PubMed    


    January 2021
  16. MESSAS E, IJsselmuiden A, Goudot G, Vlieger S, et al
    Feasibility and Performance of Noninvasive Ultrasound Therapy in Patients With Severe Symptomatic Aortic Valve Stenosis: A First-in-Human Study.
    Circulation. 2021 Jan 25. doi: 10.1161/CIRCULATIONAHA.120.050672.
    PubMed    


  17. FORTUNI F, Bax JJ, Delgado V
    Changing the Paradigm in the Management of Valvular Heart Disease: In Addition to Left Ventricular Ejection Fraction, Focus on the Myocardium.
    Circulation. 2021;143:209-211.
    PubMed    


  18. URENA M, Vahanian A, Brochet E, Ducrocq G, et al
    Current Indications for Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valves: Valve-in-Valve, Valve-in-Ring, and Valve-in-Mitral Annulus Calcification.
    Circulation. 2021;143:178-196.
    PubMed     Abstract available


  19. BAPAT VN
    Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-Mitral Annular Calcification: Are We There Yet?
    Circulation. 2021;143:117-119.
    PubMed    


    December 2020
  20. OTTO CM, Nishimura RA, Bonow RO, Carabello BA, et al
    2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2020 Dec 17:CIR0000000000000923. doi: 10.1161/CIR.0000000000000923.
    PubMed    


  21. OTTO CM, Nishimura RA, Bonow RO, Carabello BA, et al
    2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2020 Dec 17:CIR0000000000000932. doi: 10.1161/CIR.0000000000000932.
    PubMed     Abstract available


  22. BAVRY AA, Arnaoutakis GJ
    Perspective to 2020 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease.
    Circulation. 2020 Dec 17. doi: 10.1161/CIRCULATIONAHA.120.051501.
    PubMed    


  23. MEHMOOD M
    Letter by Mehmood Regarding Article, "Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction".
    Circulation. 2020;142:e375-e376.
    PubMed    


  24. PETERZAN MA, Neubauer S, Rodgers CT, Rider OJ, et al
    Response by Peterzan et al to Letter Regarding Article, "Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction".
    Circulation. 2020;142:e377-e378.
    PubMed    


    November 2020
  25. USEINI D, Strauch J
    Letter by Useini and Strauch Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e310-e311.
    PubMed    


  26. LOARDI C, Zanobini M
    Letter by Loardi and Zanobini Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e312-e313.
    PubMed    


  27. PIBAROT P, Mack MJ, Leon MB, Hahn RT, et al
    Response by Pibarot et al to Letter Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e314-e315.
    PubMed    


  28. POLLARI F, Vogt F, Fischlein T
    Letter by Pollari et al Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e308-e309.
    PubMed    


  29. KARTHIKEYAN G, Connolly SJ, Yusuf S
    Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation.
    Circulation. 2020;142:1697-1699.
    PubMed    


    October 2020
  30. LURZ P, Unterhuber M, Rommel KP, Kresoja KP, et al
    Closure of Iatrogenic Atrial Septal Defect Following Transcatheter Mitral Valve Repair: The Randomized MITHRAS Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051989.
    PubMed    


  31. TAMBURINO C, Bleiziffer S, Thiele H, Scholtz S, et al
    Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051547.
    PubMed     Abstract available


  32. DEL VAL D, Linke A, Abdel-Wahab M, Latib A, et al
    Long-Term Outcomes After Infective Endocarditis After Transcatheter Aortic Valve Replacement.
    Circulation. 2020;142:1497-1499.
    PubMed    


  33. CHAN V, Mazer CD, Ali FM, Quan A, et al
    Randomized, Controlled Trial Comparing Mitral Valve Repair With Leaflet Resection Versus Leaflet Preservation on Functional Mitral Stenosis: The CAMRA CardioLink-2 Study.
    Circulation. 2020;142:1342-1350.
    PubMed     Abstract available


  34. HANZEL GS, Gersh BJ
    Transcatheter Aortic Valve Replacement in Low-Risk, Young Patients: Natural Expansion or Cause for Concern?
    Circulation. 2020;142:1317-1319.
    PubMed    


    September 2020
  35. SIMONATO M, Whisenant B, Barbosa Ribeiro H, Webb JG, et al
    Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement: Comprehensive Mid-Term Evaluation of Valve-in-Valve and Valve-in-Ring Implantation from the VIVID Registry.
    Circulation. 2020 Sep 25. doi: 10.1161/CIRCULATIONAHA.120.049088.
    PubMed     Abstract available


    August 2020
  36. THIELE H, Kurz T, Feistritzer HJ, Stachel G, et al
    General versus Local Anesthesia with Conscious Sedation in Transcatheter Aortic Valve Implantation: The Randomized SOLVE-TAVI Trial.
    Circulation. 2020 Aug 21. doi: 10.1161/CIRCULATIONAHA.120.046451.
    PubMed     Abstract available


  37. TUCKER NR, Chaffin M, Bedi KC Jr, Papangeli I, et al
    Myocyte-Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2-Mediated Myocarditis.
    Circulation. 2020;142:708-710.
    PubMed    


    July 2020
  38. MICHELENA HI, Vallabhajosyula S, Prakash SK
    Nosology Spectrum of the Bicuspid Aortic Valve Condition: Complex-Presentation Valvulo-Aortopathy.
    Circulation. 2020;142:294-299.
    PubMed    


    June 2020
  39. ABBAS AE
    Letter by Abbas Regarding Articles, "Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry" and "Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expand
    Circulation. 2020;141:e908-e909.
    PubMed    


  40. DEHARO P, Bisson A, Saint Etienne C, Fauchier L, et al
    Response by Deharo et al to Letter Regarding Article, "Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis: Data From a Nationwide Analysis".
    Circulation. 2020;141:e912-e913.
    PubMed    


  41. VINCENT F, Ternacle J, Delhaye C, Auffret V, et al
    Response by Vincent et al to Letter Regarding Article, "Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry".
    Circulation. 2020;141:e910-e911.
    PubMed    


  42. ARTIACH G, Carracedo M, Plunde O, Wheelock CE, et al
    Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease through the Resolvin E1 and ChemR23 Axis.
    Circulation. 2020 Jun 8. doi: 10.1161/CIRCULATIONAHA.119.041868.
    PubMed     Abstract available


  43. TAM DY, Wijeysundera HC, Naimark D, Gaudino M, et al
    Impact of Transcatheter Aortic Valve Durability on Life Expectancy in Low Risk Patients with Severe Aortic Stenosis.
    Circulation. 2020 Jun 4. doi: 10.1161/CIRCULATIONAHA.119.044559.
    PubMed     Abstract available



  44. Correction to: Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry.
    Circulation. 2020;141:e879.
    PubMed    


    May 2020

  45. Correction to: Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
    Circulation. 2020;141:e836.
    PubMed    


  46. PETERZAN MA, Clarke WT, Lygate CA, Lake HA, et al
    Cardiac Energetics in Patients with Aortic Stenosis and Preserved versus Reduced Ejection Fraction.
    Circulation. 2020 May 22. doi: 10.1161/CIRCULATIONAHA.119.043450.
    PubMed     Abstract available


  47. STROM JB, Faridi KF, Butala NM, Zhao Y, et al
    Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings from the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.120.046159.
    PubMed     Abstract available


  48. DELGADO V, Kumbhani DJ
    Cardiac and Vascular Changes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Aortic Stenosis.
    Circulation. 2020;141:1538-1540.
    PubMed    


    April 2020
  49. MARSTRAND P, Han L, Day SM, Olivotto I, et al
    Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.
    Circulation. 2020;141:1371-1383.
    PubMed     Abstract available


  50. PIBAROT P, Salaun E, Dahou A, Avenatti E, et al
    Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
    Circulation. 2020 Apr 10. doi: 10.1161/CIRCULATIONAHA.119.044574.
    PubMed     Abstract available


  51. LI S, Nguyen NUN, Xiao F, Menendez-Montes I, et al
    Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation.
    Circulation. 2020 Apr 10. doi: 10.1161/CIRCULATIONAHA.119.043939.
    PubMed     Abstract available


    March 2020
  52. WEISSLER-SNIR A, Dorian P
    Response by Weissler-Snir and Dorian to Letter Regarding Article, "Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario".
    Circulation. 2020;141:e703-e704.
    PubMed    


  53. MADIAS JE
    Letter by Madias Regarding Article, "Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario".
    Circulation. 2020;141:e701-e702.
    PubMed    


  54. YADGIR S, Johnson CO, Aboyans V, Adebayo OM, et al
    Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.119.043391.
    PubMed     Abstract available


  55. TOEPFER CN, Garfinkel AC, Venturini G, Wakimoto H, et al
    Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy.
    Circulation. 2020;141:828-842.
    PubMed     Abstract available


    February 2020
  56. HALIM SA, Edwards FH, Dai D, Li Z, et al
    Outcomes of Transcatheter Aortic Valve Replacement in Patients with Bicuspid Aortic Valve Disease: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Circulation. 2020 Feb 26. doi: 10.1161/CIRCULATIONAHA.119.040333.
    PubMed     Abstract available


    January 2020
  57. ABDEL-WAHAB M, Thiele H
    Transcatheter Heart Valve Design and Mortality: Truth or Dare?
    Circulation. 2020;141:269-272.
    PubMed    


  58. LUETKENS JA, Faron A, Geissler HL, Al-Kassou B, et al
    Opportunistic Computed Tomography Imaging for the Assessment of Fatty Muscle Fraction Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Circulation. 2020;141:234-236.
    PubMed    



  59. Correction to: Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study.
    Circulation. 2020;141:e54.
    PubMed    


  60. KIM AJ, Xu N, Umeyama K, Hulin A, et al
    Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
    Circulation. 2020;141:132-146.
    PubMed     Abstract available


  61. FAYSSOIL A
    Letter by Fayssoil Regarding Article, "Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction".
    Circulation. 2020;141:e1-e2.
    PubMed    


    December 2019
  62. KITKUNGVAN D, Yang EY, El Tallawi KC, Nagueh SF, et al
    Prognostic Implications of Diffuse Interstitial Fibrosis in Asymptomatic Primary Mitral Regurgitation.
    Circulation. 2019;140:2122-2124.
    PubMed    


    November 2019
  63. SLOSTAD BD, Witt CM, O'Leary PW, Maleszewski JJ, et al
    Unicuspid Aortic Valve: Demographics, Comorbidities, Echocardiographic Features, and Long-Term Outcomes.
    Circulation. 2019;140:1853-1855.
    PubMed    


  64. VAN BELLE E, Vincent F, Labreuche J, Auffret V, et al
    Balloon-Expandable versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison from The France-TAVI Registry.
    Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.043785.
    PubMed     Abstract available


  65. DEHARO P, Bisson A, Herbert J, Lacour T, et al
    Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis: Data from a Nationwide Analysis.
    Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.043971.
    PubMed     Abstract available


  66. RAGGI P, Bellasi A, Bushinsky D, Bover J, et al
    Slowing Progression of Cardiovascular Calcification with SNF472 in Patients on Hemodialysis: Results of a Randomized, Phase 2b Study.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044195.
    PubMed     Abstract available


    October 2019
  67. KANEKO T
    Killing Two Birds With One Stone: Complete Percutaneous Approach to Aortic Valve Replacement and Revascularization.
    Circulation. 2019;140:1306-1307.
    PubMed    


  68. KATO N, Padang R, Pislaru C, Miranda WR, et al
    Hemodynamics and Prognostic Impact of Concomitant Mitral Stenosis in Patients Undergoing Surgical or Transcatheter Aortic Valve Replacement for Aortic Stenosis.
    Circulation. 2019;140:1251-1260.
    PubMed     Abstract available


  69. DONNELLAN E, Alashi A, Johnston DR, Gillinov AM, et al
    Outcomes of Patients With Mediastinal Radiation-Associated Mitral Valve Disease Undergoing Cardiac Surgery.
    Circulation. 2019;140:1288-1290.
    PubMed    


  70. RUEL M, Gardner TJ
    Introduction to the 2019 Cardiovascular Surgery-Themed Issue.
    Circulation. 2019;140:1231-1232.
    PubMed    


    September 2019
  71. BONOW RO, Mark DB, O'Gara PT
    Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation.
    Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043408.
    PubMed    


  72. BARON SJ, Wang K, Arnold SV, Magnuson EA, et al
    Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.
    Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043275.
    PubMed     Abstract available


  73. DESAI MY, Svensson LG
    Chronic Severe Aortic Regurgitation: Should We Lower Operating Thresholds?
    Circulation. 2019;140:1045-1047.
    PubMed    


  74. IUNG B, Delgado V, Rosenhek R, Price S, et al
    Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Circulation. 2019 Sep 12. doi: 10.1161/CIRCULATIONAHA.119.041080.
    PubMed     Abstract available


  75. BASSO C, Iliceto S, Thiene G, Perazzolo Marra M, et al
    Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death.
    Circulation. 2019;140:952-964.
    PubMed     Abstract available


  76. KUNDI H, Faridi KF, Wang Y, Wadhera RK, et al
    Geographic Patterns of Growth for Transcatheter Aortic Valve Replacement in the United States.
    Circulation. 2019;140:969-971.
    PubMed    


  77. BENNETT AJ, Carter S, Joglar JA
    A New Tachyarrhythmia in a 60-Year-Old Woman.
    Circulation. 2019;140:965-968.
    PubMed    


  78. TANG GHL, Verma S, Bhatt DL
    Transcatheter Aortic Valve Replacement in Low-Risk Patients.
    Circulation. 2019;140:801-803.
    PubMed    


  79. SONDERGAARD L, Popma JJ, Reardon MJ, Van Mieghem NM, et al
    Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial.
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.118.039564.
    PubMed     Abstract available


    August 2019
  80. KHIRFAN G, Ahmed MK, Almaaitah S, Almoushref A, et al
    Comparison of Different Methods to Estimate Cardiac Index in Pulmonary Arterial Hypertension.
    Circulation. 2019;140:705-707.
    PubMed    


  81. FULMER D, Toomer K, Guo L, Moore K, et al
    Defects in the Exocyst-Cilia Machinery Cause Bicuspid Aortic Valve Disease and Aortic Stenosis.
    Circulation. 2019 Aug 7. doi: 10.1161/CIRCULATIONAHA.119.038376.
    PubMed     Abstract available


    July 2019
  82. AILAWADI G, Lim DS, Grayburn PA
    Response by Ailawadi et al to Letter Regarding Article, "One-Year Outcomes After MitraClip for Functional Mitral Regurgitation".
    Circulation. 2019;140:e175-e176.
    PubMed    


  83. GUL EE, Haseeb S
    Letter by Gul and Haseeb Regarding Article, "One-Year Outcomes After MitraClip for Functional Mitral Regurgitation".
    Circulation. 2019;140:e173-e174.
    PubMed    


  84. MITAL S, Ommen S
    To Screen or Not to Screen, That Is the Question.
    Circulation. 2019;140:193-195.
    PubMed    


  85. SIGWART U
    Therapeutic Myocardial Infarction for Hypertrophic Obstructive Cardiomyopathy: Is It Appropriate?
    Circulation. 2019;140:11-12.
    PubMed    


    June 2019
  86. DIETZ MF, Prihadi EA, van der Bijl P, Goedemans L, et al
    Prognostic Implications of Right Ventricular Remodeling and Function in Patients with Significant Secondary Tricuspid Regurgitation.
    Circulation. 2019 Jun 12. doi: 10.1161/CIRCULATIONAHA.119.039630.
    PubMed     Abstract available


  87. PRENDERGAST BD, Redwood SR
    Transcatheter Aortic Valve Replacement.
    Circulation. 2019;139:2724-2727.
    PubMed    


  88. MIRTSCHINK P, Bischof C, Pham MD, Sharma R, et al
    Inhibition of the Hypoxia-Inducible Factor 1alpha-Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart Disease.
    Circulation. 2019;139:2778-2792.
    PubMed     Abstract available


  89. GUALA A, Rodriguez-Palomares J, Galian-Gay L, Teixido-Tura G, et al
    Partial Aortic Valve Leaflet Fusion Is Related to Deleterious Alteration of Proximal Aorta Hemodynamics.
    Circulation. 2019;139:2707-2709.
    PubMed    


  90. FREITAS-FERRAZ AB, Tirado-Conte G, Dagenais F, Ruel M, et al
    Aortic Stenosis and Small Aortic Annulus.
    Circulation. 2019;139:2685-2702.
    PubMed     Abstract available


    May 2019
  91. BENFARI G, Antoine C, Miller WL, Thapa P, et al
    Excess Mortality Associated with Functional Tricuspid Regurgitation Complicating Heart Failure with Reduced Ejection Fraction.
    Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038946.
    PubMed     Abstract available


  92. ENRIQUEZ-SARANO M, Michelena HI, Grigioni F
    Treatment of Functional Mitral Regurgitation.
    Circulation. 2019;139:2289-2291.
    PubMed    


  93. SMITH GL, Eisner DA
    Calcium Buffering in the Heart in Health and Disease.
    Circulation. 2019;139:2358-2371.
    PubMed     Abstract available


  94. REDDY YNV, Nishimura RA
    Paradox of Low-Gradient Aortic Stenosis.
    Circulation. 2019;139:2195-2197.
    PubMed    


  95. PACKER M, Grayburn PA
    Contrasting Effects of Pharmacological, Procedural and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure.
    Circulation. 2019 May 1. doi: 10.1161/CIRCULATIONAHA.119.039612.
    PubMed     Abstract available


    March 2019
  96. MARON BJ, Rowin EJ, Maron MS
    Letter by Maron et al Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".
    Circulation. 2019;139:1557-1558.
    PubMed    


  97. HO CY, Day SM, Ashley EA, Michels M, et al
    Response by Ho et al to Letter Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".
    Circulation. 2019;139:1559-1560.
    PubMed    


  98. LEHMAN SJ, Tal-Grinspan L, Lynn ML, Strom J, et al
    Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.
    Circulation. 2019;139:1517-1529.
    PubMed     Abstract available


  99. ENRIQUEZ-SARANO M, Antoine C
    Response by Enriquez-Sarano and Antoine to Letter Regarding Article, "Clinical Outcome of Degenerative Mitral Regurgitation: Critical Importance of Echocardiographic Quantitative Assessment in Routine Practice".
    Circulation. 2019;139:1465-1466.
    PubMed    


  100. PAL N
    Letter by Pal Regarding Article, "Clinical Outcome of Degenerative Mitral Regurgitation: Critical Importance of Echocardiographic Quantitative Assessment in Routine Practice".
    Circulation. 2019;139:1463-1464.
    PubMed    


  101. MULLENS W, Martens P
    Sacubitril/Valsartan to Reduce Secondary Mitral Regurgitation.
    Circulation. 2019;139:1366-1370.
    PubMed    


    February 2019
  102. SALEEB SF, Gauvreau K, Mayer JE, Newburger JW, et al
    Aortic Valve Replacement With Bovine Pericardial Tissue Valve in Children and Young Adults.
    Circulation. 2019;139:983-985.
    PubMed    


  103. CARRIER L
    Making Sense of Inhibiting Nonsense in Hypertrophic Cardiomyopathy.
    Circulation. 2019;139:812-814.
    PubMed    


  104. UDELSON JE
    Evaluating and Reducing the Risk of Sudden Death in Hypertrophic Cardiomyopathy.
    Circulation. 2019;139:727-729.
    PubMed    


  105. MAURIZI N, Michels M, Rowin EJ, Semsarian C, et al
    Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.
    Circulation. 2019;139:830-833.
    PubMed    


  106. SEEGER T, Shrestha R, Lam CK, Chen C, et al
    A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.
    Circulation. 2019;139:799-811.
    PubMed     Abstract available


  107. LEE DP, Tan WLW, Anene-Nzelu CG, Lee CJM, et al
    A Robust CTCF-Based Chromatin Architecture Underpins Epigenetic Changes in the Heart Failure Stress-Gene Response.
    Circulation. 2019 Feb 5. doi: 10.1161/CIRCULATIONAHA.118.036726.
    PubMed     Abstract available


  108. THYREGOD HGH, Ihlemann N, Jorgensen TH, Nissen H, et al
    Five-Year Clinical and Echocardiographic Outcomes from the Nordic Aortic Valve Intervention (NOTION) Randomized Clinical Trial in Lower Surgical Risk Patients.
    Circulation. 2019 Feb 1. doi: 10.1161/CIRCULATIONAHA.118.036606.
    PubMed     Abstract available


    January 2019
  109. BAUMGARTNER H
    Has the Time Come to Recommend Percutaneous Mitral Edge-to-Edge Repair for Severe Secondary Mitral Regurgitation?
    Circulation. 2019;139:48-50.
    PubMed    


  110. AILAWADI G, Lim DS, Mack MJ, Trento A, et al
    One-Year Outcomes After MitraClip for Functional Mitral Regurgitation.
    Circulation. 2019;139:37-47.
    PubMed     Abstract available


    December 2018
  111. KANG DH, Park SJ, Shin SH, Hong GR, et al
    Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study.
    Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.037077.
    PubMed     Abstract available


  112. ASGAR AW
    Transcatheter Aortic Valve Replacement and Valve Durability.
    Circulation. 2018;138:2608-2610.
    PubMed    


  113. FIORILLI PN, Giri J
    Should Transcatheter Aortic Valve Replacement Be the Procedure of Choice for Intermediate-Risk Patients With Severe Aortic Stenosis?
    Circulation. 2018;138:2624-2626.
    PubMed    


  114. DIDIER R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, et al
    Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients.
    Circulation. 2018;138:2597-2607.
    PubMed     Abstract available


  115. WERNER N, Zahn R, Beckmann A, Bauer T, et al
    Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve Stenosis.
    Circulation. 2018;138:2611-2623.
    PubMed     Abstract available


    November 2018
  116. BARON SJ, Wang K, House JA, Magnuson EA, et al
    Cost-Effectiveness of Transcatheter vs. Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Intermediate Risk:Results from the PARTNER 2 Trial.
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.118.035236.
    PubMed     Abstract available


    October 2018
  117. YAGISHITA A, Goya M, Hirao K
    Simultaneous Recording of the P Wave During Atrial Fibrillation.
    Circulation. 2018;138:2057-2060.
    PubMed    


  118. VAKAMUDI S, Jellis C, Mick S, Wu Y, et al
    Sex Differences in the Etiology of Surgical Mitral Valve Disease.
    Circulation. 2018;138:1749-1751.
    PubMed    


  119. DONNELLAN E, Krishnaswamy A, Hutt-Centeno E, Johnston DR, et al
    Outcomes of Patients With Mediastinal Radiation-Associated Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
    Circulation. 2018;138:1752-1754.
    PubMed    


  120. SPIEWAK M
    Letter by Spiewak Regarding Article, "Prognostic Implications of Magnetic Resonance-Derived Quantification in Asymptomatic Patients With Organic Mitral Regurgitation: Comparison With Doppler Echocardiography-Derived Integrative Approach".
    Circulation. 2018;138:1608-1609.
    PubMed    


  121. PENICKA M
    Response by Penicka to Letter Regarding Article, "Prognostic Implications of Magnetic Resonance-Derived Quantification in Asymptomatic Patients With Organic Mitral Regurgitation: Comparison With Doppler Echocardiography-Derived Integrative Approach".
    Circulation. 2018;138:1610-1611.
    PubMed    


    September 2018
  122. URETSKY S, Gillam LD
    Revisiting and Confirming the Prognostic Importance of Effective Regurgitant Orifice Area in Degenerative Mitral Regurgitation.
    Circulation. 2018;138:1327-1329.
    PubMed    


  123. GILLAM LD, Koulogiannis KP, Marcoff L
    Bioprosthetic Aortic Valve Deterioration.
    Circulation. 2018;138:986-988.
    PubMed    


  124. HOURDAIN J, Clavel MA, Deharo JC, Asirvatham S, et al
    Common Phenotype in Patients With Mitral Valve Prolapse Who Experienced Sudden Cardiac Death.
    Circulation. 2018;138:1067-1069.
    PubMed    


  125. SALAUN E, Mahjoub H, Girerd N, Dagenais F, et al
    Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement.
    Circulation. 2018;138:971-985.
    PubMed     Abstract available


    August 2018
  126. COLLI A, Manzan E, Besola L, Bizzotto E, et al
    One-Year Outcomes After Transapical Echocardiography-Guided Mitral Valve Repair.
    Circulation. 2018;138:843-845.
    PubMed    



  127. Correction to: Myeloid Cells Remodel the Mitral Valve.
    Circulation. 2018;138:e125.
    PubMed    


    July 2018
  128. GOMES AV
    Spatiotemporal Multi-Omics-Derived Atlas of Calcific Aortic Valve Disease.
    Circulation. 2018;138:394-396.
    PubMed    


  129. MUSA TA, Treibel TA, Vassiliou VS, Captur G, et al
    Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium.
    Circulation. 2018 Jul 12. pii: CIRCULATIONAHA.117.032839.
    PubMed     Abstract available


  130. SORAJJA P, Ailawadi G
    Argument for Prophylactic, Catheter-Based Repair of Mitral Regurgitation.
    Circulation. 2018;138:125-127.
    PubMed    


  131. GOLDFARB M, Lauck S, Webb JG, Asgar AW, et al
    Malnutrition and Mortality in Frail and Non-Frail Older Adults Undergoing Aortic Valve Replacement.
    Circulation. 2018 Jul 5. pii: CIRCULATIONAHA.118.033887.
    PubMed     Abstract available


    June 2018
  132. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Circulation. 2018;137:2635-2650.
    PubMed     Abstract available


  133. HYMAN MC, Patel PA, Giri J
    Response by Hyman et al to Letter Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights From the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Car
    Circulation. 2018;137:2545-2546.
    PubMed    


  134. SNIECINSKI RM, Mackensen GB, Kertai MD
    Letter by Sniecinski et al Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology
    Circulation. 2018;137:2543-2544.
    PubMed    


  135. CREMER S, Nahrendorf M
    Myeloid Cells Remodel the Mitral Valve.
    Circulation. 2018;137:2494-2496.
    PubMed    


  136. ROWIN EJ, Maron MS, Maron BJ
    Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2541-2542.
    PubMed    


  137. WANG L, Zhao YT
    Letter by Wang and Zhao Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2540.
    PubMed    


  138. ZHANG L, Xu XM
    Letter by Zhang and Xu Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2539.
    PubMed    


    May 2018
  139. ANTOINE C, Benfari G, Michelena HI, Malouf JF, et al
    Clinical Outcome of Degenerative Mitral Regurgitation: Critical Importance of Echocardiographic Quantitative Assessment in Routine Practice.
    Circulation. 2018 May 31. pii: CIRCULATIONAHA.117.033173.
    PubMed     Abstract available


  140. HENG EL, Diller GP, Gatzoulis MA, Babu-Narayan SV, et al
    Response by Heng et al to Letter Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2186-2187.
    PubMed    


  141. ROMEO JLR, Bogers AJJC, Mokhles MM
    Letter by Romeo et al Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2184-2185.
    PubMed    


  142. CASELLI S, Mango F, Clark J, Pandian NG, et al
    Prevalence and Clinical Outcome of Athletes With Mitral Valve Prolapse.
    Circulation. 2018;137:2080-2082.
    PubMed    


    April 2018
  143. BRAUNWALD E
    Aortic Stenosis: Then and Now.
    Circulation. 2018 Apr 12. pii: CIRCULATIONAHA.118.033408.
    PubMed     Abstract available


    March 2018
  144. SCHLOTTER F, Halu A, Goto S, Blaser MC, et al
    Spatiotemporal Multi-omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving Disease.
    Circulation. 2018 Mar 27. pii: CIRCULATIONAHA.117.032291.
    PubMed     Abstract available


  145. DELGADO V, Hundley WG
    Added Value of Cardiovascular Magnetic Resonance in Primary Mitral Regurgitation.
    Circulation. 2018;137:1361-1363.
    PubMed    


  146. GHARIBEH L, Komati H, Bosse Y, Boodhwani M, et al
    GATA6 Regulates Aortic Valve Remodeling and its Haploinsufficiency Leads to RL-Type Bicuspid Aortic Valve.
    Circulation. 2018 Mar 22. pii: CIRCULATIONAHA.117.029506.
    PubMed     Abstract available


  147. ZAUNER CA, Holshouser JW, Littmann L
    Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease.
    Circulation. 2018;137:1287-1289.
    PubMed    


  148. ASCH FM, Vannan MA, Singh S, Khandheria B, et al
    Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial (Repositionable Percutaneous Replacement
    Circulation. 2018 Mar 12. pii: CIRCULATIONAHA.118.034129.
    PubMed     Abstract available


  149. ELBAZ-GREENER G, Masih S, Fang J, Ko DT, et al
    Temporal Trends and Clinical Consequences of Wait-Times for Trans-Catheter Aortic Valve Replacement: A Population Based Study.
    Circulation. 2018 Mar 6. pii: CIRCULATIONAHA.117.033432.
    PubMed     Abstract available


  150. HO CY, Link MS
    Predicting the Future in Hypertrophic Cardiomyopathy.
    Circulation. 2018;137:1024-1026.
    PubMed    


    February 2018
  151. LJUNGBERG J, Janiec M, Bergdahl IA, Holmgren A, et al
    Proteomic Biomarkers for Incident Aortic Stenosis Requiring Valvular Replacement.
    Circulation. 2018 Feb 27. pii: CIRCULATIONAHA.117.030414.
    PubMed     Abstract available


  152. VAN HAGEN IM, Thorne SA, Taha N, Youssef G, et al
    Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease.
    Circulation. 2018;137:806-816.
    PubMed     Abstract available


  153. FRENCH KA, Poppas A
    Rheumatic Heart Disease in Pregnancy: Global Challenges and Clear Opportunities.
    Circulation. 2018;137:817-819.
    PubMed    


  154. FRIEDMAN DJ, Parzynski CS, Heist EK, Russo AM, et al
    Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry.
    Circulation. 2018 Feb 20. pii: CIRCULATIONAHA.117.032167.
    PubMed     Abstract available


    January 2018
  155. PELLICCIA A, Lemme E, Maestrini V, Di Paolo FM, et al
    Does Sport Participation Worsen the Clinical Course of Hypertrophic Cardiomyopathy? Clinical Outcome of Hypertrophic Cardiomyopathy in Athletes.
    Circulation. 2018;137:531-533.
    PubMed    


  156. SABERI S, Day SM
    Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart.
    Circulation. 2018;137:419-421.
    PubMed    


  157. DVIR D, Bourguignon T, Otto CM, Hahn RT, et al
    Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.
    Circulation. 2018;137:388-399.
    PubMed     Abstract available


  158. GLASER N, Jackson V, Holzmann MJ, Franco-Cereceda A, et al
    Response by Glaser et al to Letter Regarding Article, "Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement".
    Circulation. 2018;137:312-313.
    PubMed    


  159. MADIAS JE
    Letter by Madias Regarding Article, "Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement".
    Circulation. 2018;137:310-311.
    PubMed    


  160. LEE JKT, Franzone A, Lanz J, Siontis GCM, et al
    Early Detection of Subclinical Myocardial Damage in Chronic Aortic Regurgitation and Strategies for Timely Treatment of Asymptomatic Patients.
    Circulation. 2018;137:184-196.
    PubMed     Abstract available


    December 2017
  161. PENICKA M, Vecera J, Mirica DC, Kotrc M, et al
    Prognostic Implications of Magnetic Resonance - Derived Quantification in Asymptomatic Patients with Organic Mitral Regurgitation: Comparison with Doppler Echocardiography-Derived Integrative Approach.
    Circulation. 2017 Dec 21. pii: CIRCULATIONAHA.117.029332.
    PubMed     Abstract available


  162. SPIRITO P
    Atrial Fibrillation in Hypertrophic Cardiomyopathy: New Light on an Old Problem.
    Circulation. 2017;136:2437-2439.
    PubMed    


    November 2017
  163. BROWN CH 4TH, Hasan RK, Brady MB
    Is Less Really More? Conscious Sedation or General Anesthesia for Transcatheter Aortic Valve Replacement.
    Circulation. 2017;136:2141-2143.
    PubMed    


  164. ROCHA RV, Manlhiot C, Feindel CM, Yau TM, et al
    Surgical Enlargement of the Aortic Root Does Not Increase the Operative Risk of Aortic Valve Replacement.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.030525.
    PubMed     Abstract available


  165. YAMAMOTO M, Shimura T, Hayashida K
    Response by Yamamoto et al to Letter Regarding Article, "Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement".
    Circulation. 2017;136:1987-1988.
    PubMed    


  166. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement".
    Circulation. 2017;136:1985-1986.
    PubMed    


  167. REDFORS B, Genereux P
    Response by Redfors and Genereux to Letter Regarding Article, "Stress Testing in Asymptomatic Aortic Stenosis".
    Circulation. 2017;136:1868-1869.
    PubMed    


  168. TZANIS G, Charitos C, Nanas S
    Letter by Tzanis et al Regarding Article, "Stress Testing in Asymptomatic Aortic Stenosis".
    Circulation. 2017;136:1866-1867.
    PubMed    


    October 2017
  169. CHOI B, Lee S, Chang EJ, Song JK, et al
    Response by Choi et al to Letters Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".
    Circulation. 2017;136:1672-1673.
    PubMed    


  170. BELLIEN J, Kamel S
    Letter by Bellien and Kamel Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".
    Circulation. 2017;136:1670-1671.
    PubMed    


  171. KOH KK
    Letter by Koh Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".
    Circulation. 2017;136:1668-1669.
    PubMed    


  172. KAPADIA S, Tuzcu EM, Svensson LG
    Anatomy and Flow Characteristics of Neosinus: Important Consideration for Thrombosis of Transcatheter Aortic Valves.
    Circulation. 2017;136:1610-1612.
    PubMed    


  173. FUKUNAGA N, Rao V
    Letter by Fukunaga and Rao Regarding Article, "Transcatheter Treatment of Severe Tricuspid Regurgitation With the Edge-to-Edge MitraClip Technique".
    Circulation. 2017;136:1357-1358.
    PubMed    


    September 2017
  174. ROWIN EJ, Hausvater A, Link MS, Abt P, et al
    Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267.
    PubMed     Abstract available


  175. AUFFRET V, Puri R, Urena M, Chamandi C, et al
    Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives.
    Circulation. 2017;136:1049-1069.
    PubMed     Abstract available


  176. HYMAN MC, Vemulapalli S, Szeto WY, Stebbins A, et al
    Conscious Sedation versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the NCDR(R) STS/ACC TVT Registry.
    Circulation. 2017 Sep 1. pii: CIRCULATIONAHA.116.026656.
    PubMed     Abstract available


    July 2017
  177. SORAJJA P, Leon MB, Adams DH, Webb JG, et al
    Transcatheter Therapy for Mitral Regurgitation Clinical Challenges and Potential Solutions.
    Circulation. 2017;136:404-417.
    PubMed     Abstract available


  178. GLASER N, Jackson V, Holzmann MJ, Franco-Cereceda A, et al
    Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement.
    Circulation. 2017;136:329-331.
    PubMed    


    June 2017
  179. CLARK CR, Bowler MA, Snider JC, Merryman WD, et al
    Targeting Cadherin-11 Prevents Notch1-Mediated Calcific Aortic Valve Disease.
    Circulation. 2017;135:2448-2450.
    PubMed    


  180. ABDUL-JAWAD ALTISENT O, Puri R, Regueiro A, Chamandi C, et al
    Predictors and Association with Clinical Outcomes of the Changes in Exercise Capacity Following Transcatheter Aortic Valve Replacement.
    Circulation. 2017 Jun 6. pii: CIRCULATIONAHA.116.026349.
    PubMed     Abstract available


    May 2017
  181. BRANDENBURG VM, Reinartz S, Kaesler N, Kruger T, et al
    Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study.
    Circulation. 2017;135:2081-2083.
    PubMed    


  182. REDFORS B, Pibarot P, Gillam LD, Burkhoff D, et al
    Stress Testing in Asymptomatic Aortic Stenosis.
    Circulation. 2017;135:1956-1976.
    PubMed     Abstract available


  183. AIKAWA E, Libby P
    A Rock and a Hard Place: Chiseling Away at the Multiple Mechanisms of Aortic Stenosis.
    Circulation. 2017;135:1951-1955.
    PubMed    



  184. Correction to: Percutaneous Therapy for Tricuspid Regurgitation: A New Frontier for Interventional Cardiology.
    Circulation. 2017;135:e1041.
    PubMed    


  185. HOLMES DR, Mack MJ
    Aortic Valve Bioprostheses: Leaflet Immobility and Valve Thrombosis.
    Circulation. 2017;135:1749-1756.
    PubMed     Abstract available


    March 2017
  186. KAPADIA SR, Krishnaswamy A, Tuzcu EM
    Percutaneous Therapy for Tricuspid Regurgitation: A New Frontier for Interventional Cardiology.
    Circulation. 2017 Mar 23. pii: CIRCULATIONAHA.116.026533.
    PubMed     Abstract available


  187. NICKENIG G, Kowalski M, Hausleiter J, Braun D, et al
    Transcatheter Treatment of Severe Tricuspid Regurgitation with the Edge-to-Edge: MitraClip Technique.
    Circulation. 2017 Mar 23. pii: CIRCULATIONAHA.116.024848.
    PubMed     Abstract available


  188. CAPOULADE R, Bowdish M, Kron IL, Smith P, et al
    Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".
    Circulation. 2017;135:e785-e786.
    PubMed    


  189. POCAR M
    Letter by Pocar Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".
    Circulation. 2017;135:e783-e784.
    PubMed    


  190. CAIRNS BJ, Coffey S, Travis RC, Prendergast B, et al
    A Replicated, Genome-Wide Significant Association of Aortic Stenosis With a Genetic Variant for Lipoprotein(a): Meta-Analysis of Published and Novel Data.
    Circulation. 2017;135:1181-1183.
    PubMed    


  191. BRIFFA N, Chambers JB
    Biological Valves in Younger Patients Undergoing Aortic Valve Replacement: A Word of Caution.
    Circulation. 2017;135:1101-1103.
    PubMed    


  192. WENDLER O, Schymik G, Treede H, Baumgartner H, et al
    SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.
    Circulation. 2017;135:1123-1132.
    PubMed     Abstract available


  193. SHIMURA T, Yamamoto M, Kano S, Kagase A, et al
    Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement.
    Circulation. 2017 Mar 16. pii: CIRCULATIONAHA.116.025630.
    PubMed     Abstract available


  194. NISHIMURA RA, Otto CM, Bonow RO, Carabello BA, et al
    2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2017 Mar 15. pii: CIR.0000000000000503.
    PubMed    


    February 2017
  195. SIONTIS KC, Yao X, Gersh BJ, Noseworthy PA, et al
    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis.
    Circulation. 2017;135:714-716.
    PubMed    


  196. CHOI B, Lee S, Kim SM, Lee EJ, et al
    Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-like Growth Factor-1 Signaling in Valvular Interstitial Cells.
    Circulation. 2017 Feb 8. pii: CIRCULATIONAHA.116.024270.
    PubMed     Abstract available


    January 2017
  197. PRENDERGAST BD, De Bonis M
    Valve Repair: A Durable Surgical Option in Degenerative Mitral Regurgitation.
    Circulation. 2017;135:423-425.
    PubMed    


  198. GAMMIE JS, Wilson P, Bartus K, Gackowski A, et al
    Response by Gammie et al to Letter Regarding Article, "Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device: Initial Clinical Experience".
    Circulation. 2017;135:e18-e19.
    PubMed    


  199. COLLI A, Gerosa G
    Letter by Colli and Gerosa Regarding Article, "Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device: Initial Clinical Experience".
    Circulation. 2017;135:e16-e17.
    PubMed    


  200. BERTRAND PB, Schwammenthal E, Levine RA, Vandervoort PM, et al
    Exercise Dynamics in Secondary Mitral Regurgitation: Pathophysiology and Therapeutic Implications.
    Circulation. 2017;135:297-314.
    PubMed     Abstract available


    November 2016
  201. LAZAM S, Vanoverschelde JL, Tribouilloy C, Grigioni F, et al
    Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation. Analysis of a Large, Prospective, Multicenter International Registry.
    Circulation. 2016 Nov 29. pii: CIRCULATIONAHA.116.023340.
    PubMed     Abstract available


  202. MARQUIS-GRAVEL G, Redfors B, Leon MB, Genereux P, et al
    Medical Treatment of Aortic Stenosis.
    Circulation. 2016;134:1766-1784.
    PubMed     Abstract available


  203. HELMS AS, Alvarado FJ, Yob J, Tang VT, et al
    Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy.
    Circulation. 2016;134:1738-1748.
    PubMed     Abstract available


  204. REYNOLDS MR, Baron SJ, Cohen DJ
    Economic Implications of Transcatheter Aortic Valve Replacement in Patients at Intermediate Surgical Risk.
    Circulation. 2016;134:1416-1418.
    PubMed    


    October 2016
  205. HADJI F, Boulanger MC, Guay SP, Gaudreault N, et al
    Altered DNA Methylation of Long Non-coding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1.
    Circulation. 2016 Oct 27. pii: CIRCULATIONAHA.116.023116.
    PubMed     Abstract available


  206. MERRYMAN WD, Clark CR
    Lnc-ing NOTCH1 to Idiopathic Calcific Aortic Valve Disease.
    Circulation. 2016 Oct 27. pii: CIRCULATIONAHA.116.025601.
    PubMed     Abstract available


  207. CAPOULADE R, Zeng X, Overbey JR, Ailawadi G, et al
    Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty.
    Circulation. 2016;134:1247-1256.
    PubMed     Abstract available


  208. MASRI A, Kalahasti V, Svensson LG, Roselli EE, et al
    Aortic Cross-Sectional Area/Height Ratio and Outcomes in Patients with a Trileaflet Aortic Valve and a Dilated Aorta.
    Circulation. 2016 Oct 21. pii: CIRCULATIONAHA.116.022995.
    PubMed     Abstract available


    July 2016
  209. NGO D, Sinha S, Shen D, Kuhn EW, et al
    Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
    Circulation. 2016;134:270-85.
    PubMed     Abstract available


    May 2016
  210. GANDHI S, Ganame J, Whitlock R, Chu V, et al
    Double Trouble: A Case of Valvular Disease in Pregnancy.
    Circulation. 2016;133:2206-11.
    PubMed    


  211. JELLIS CL, Navia JL, Flamm SD, Rodriguez LL, et al
    Severe Functional Tricuspid Stenosis Secondary to a Giant Saphenous Vein Bypass Graft Aneurysm.
    Circulation. 2016;133:2099-102.
    PubMed    


  212. HEAD SJ, Mylotte D, Mack MJ, Piazza N, et al
    Considerations and Recommendations for the Introduction of Objective Performance Criteria for Transcatheter Aortic Heart Valve Device Approval.
    Circulation. 2016;133:2086-93.
    PubMed     Abstract available


  213. MACINTYRE C, Lakdawala NK
    Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2016;133:1901-5.
    PubMed    


    April 2016
  214. MCELHINNEY DB, Cabalka AK, Aboulhosn JA, Eicken A, et al
    Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An International, Multicenter Registry Study.
    Circulation. 2016;133:1582-93.
    PubMed     Abstract available


  215. VAHL TP, Hahn RT, Moses JW
    Transcatheter Valve-in-Valve Implantation for Failing Bioprosthetic Triscupid Valves: Completing the Quest.
    Circulation. 2016;133:1537-9.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: